Disease-modifying therapy in MS: a critical review of the literature
- 1 September 2004
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 251 (5) , v3-v11
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Stressful Life Events Precede Exacerbations of Multiple SclerosisPsychosomatic Medicine, 2002
- European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosisAnnals of Neurology, 2001
- Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 yearsMultiple Sclerosis Journal, 2000
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple SclerosisNew England Journal of Medicine, 1993
- A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic NeuritisNew England Journal of Medicine, 1992
- Applications of global statistics in analysing quality of life dataStatistics in Medicine, 1990
- More powerful procedures for multiple significance testingStatistics in Medicine, 1990
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisNew England Journal of Medicine, 1987